GILEAD SCIENCES, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 169.9 BRL | -1.92% |
|
+3.77% | -11.73% |
| 05-07 | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
| 05-02 | UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating | MT |
Quotes 5-day view
Delayed Quote Sao Paulo| 30/04/2024 | 02/05/2024 | 03/05/2024 | 07/05/2024 | 10/05/2024 | |
|---|---|---|---|---|---|
| Last | 168.96 R$ | 166 R$ | 163.75 R$ | 166.8 R$ | 169.9 R$ |
| Volume | 56 | 156 | 861 | 1 250 | 1 |
| Change | +∞% | -1.75% | -1.36% | +1.86% | -1.92% |
| Opening | 168.96 | 166.50 | 165.00 | 166.65 | 169.9 |
| High | 168.96 | 166.50 | 165.00 | 166.80 | 169.9 |
| Low | 168.96 | 166.00 | 163.75 | 166.60 | 169.9 |
Performance
| 1 day | -1.92% | ||
| 1 week | +3.77% | ||
| Current month | +0.57% | ||
| 1 month | -2.49% | ||
| 3 months | -6.16% | ||
| 6 months | -7.69% | ||
| Current year | -11.73% | ||
| 1 year | -11.61% | ||
| 3 years | -4.53% | ||
| 5 years | +33.55% |
Volumes
marketsDaily volume
1
Estimated daily volume
1
Avg. Volume 20 sessions
906
Daily volume ratio
0.00
Avg. Volume 20 sessions BRL
153 956.58
Avg. Volume 20 sessions USD
29 860.34
Record volume 1
71 700
Record volume 2
62 000
Record volume 3
53 300
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (BRL)
80 529 277 587
Capitalization (USD)
80 529 277 587
Net sales (USD)
27 116 000 000
Number of employees
18 000
Sales / Employee (USD)
1 506 444
Free-Float
99.92 %
Free-Float capitalization (BRL)
15 603 558 091
Free-Float capitalization (USD)
80 461 307 652
Average Daily Capital Traded
0%
Highs and lows
1 week
166.60
169.93
1 month
163.75177.30
Current year
163.75215.96
1 year
163.75215.96
3 years
132.24235.55
5 years
122.30238.80
10 years
102.29238.80
Indicators
Moving average 5 days
165.52
Moving average 20 days
173.12
Moving average 50 days
181.79
Moving average 100 days
185.44
Price spread / (MMA5)
-2.60%
Price spread / (MMA20)
+1.88%
Price spread / (MMA50)
+6.98%
Price spread / (MMA100)
+9.13%
STIM
RSI 9 days
34.60
RSI 14 days
34.73
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -1.92% | +3.77% | -11.73% | -11.61% | 80.53B | ||
| -1.15% | +3.46% | +30.45% | +74.43% | 695B | ||
| +0.07% | +1.16% | +26.51% | +54.70% | 568B | ||
| +0.12% | +0.31% | -4.47% | -7.37% | 361B | ||
| +0.12% | +2.25% | +19.59% | +10.59% | 330B | ||
| +0.35% | -1.84% | +3.74% | +9.80% | 283B | ||
| +0.31% | +2.66% | +16.70% | +4.65% | 239B | ||
| +1.97% | +4.94% | +8.78% | +0.41% | 204B | ||
| +1.26% | +3.59% | -7.93% | -19.66% | 198B | ||
| -2.20% | -0.13% | +7.94% | +32.80% | 168B | ||
| +1.23% | +3.32% | +5.09% | -4.53% | 125B | ||
| +1.07% | +3.81% | +24.09% | +25.28% | 90.86B | ||
| +0.50% | +2.08% | -12.48% | -34.44% | 90.69B | ||
| +3.60% | -2.13% | +39.08% | +17.50% | 64.03B | ||
| -.--% | +1.73% | - | - | 63.66B | ||
| +0.45% | -2.91% | -7.41% | +36.71% | 52.06B | ||
| Average | +0.33% | +1.17% | +9.20% | +12.62% | ||
| Weighted average by Cap. | +0.01% | +1.16% | +14.24% | +25.34% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
643157d86b9d3447c87281.dXqsObtyDdJ8hyDIzE2El6hy48XlW7q7zYK5hhe706A.O0nHTMoGZrgz9Wn8gCvU8fwqrbGwPvOJp-Tpvm3OgO89F8J31DpuvkTmbQ
| Date | Price | Volume | Daily volume |
|---|
Monthly variations
Annual change
| 2024 | -13.36% | ||
| 2023 | -13.03% | ||
| 2022 | +9.08% | ||
| 2021 | +38.30% | ||
| 2020 | +10.31% | ||
| 2019 | +9.45% | ||
| 2018 | +0.20% | ||
| 2017 | +1.20% | ||
| 2016 | -33.70% |
- Stock Market
- Equities
- GILD Stock
- GILD34 Stock
- Quotes Gilead Sciences, Inc.
